Digital Health Global

JANUARY 31, 2024

the leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials. .–(BUSINESS WIRE)–Medable Inc.,

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Digital Health Global

APRIL 16, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?

Drug Development 73

Drug Development Health science healthcare technology Leadership 73

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Co-Founder & President, and Chief Executive Officer.

Life Science 88

Life Science BioTech Drug Development Health science 88